Creative Capital Management Investments’s Dyne Therapeutics DYN Stock Holding History

Creative Capital Management Investments’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$178	Buy	+8	New	+$149	﹤0.01%	1396

Other funds holding DYN

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Creative Capital Management Investments's DYN Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 8 shares worth $178. The stake represents ﹤0.01% of the portfolio and ranks #1396 among its holdings.

27 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Creative Capital Management Investments held 8 shares of Dyne Therapeutics worth $178 as of Q2 2026.
Dyne Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
Dyne Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1396 holding.
27 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.